Grayscale has filed an S-1 with the SEC to launch the first U.S.-listed exchange-traded product offering exposure to Bittensor’s TAO token, under the proposed tickerGrayscale has filed an S-1 with the SEC to launch the first U.S.-listed exchange-traded product offering exposure to Bittensor’s TAO token, under the proposed ticker

Grayscale Targets Decentralised AI With First-Ever Bittensor (TAO) ETP Filing

  • Grayscale has filed an S-1 registration statement with the SEC to convert its Bittensor Trust into the first U.S. spot ETF for the TAO token, proposed to trade on NYSE Arca.
  • The move follows the network’s first “halving” on December 14, 2025, which reduced daily token emissions from 7,200 to 3,600 TAO to increase scarcity.
  • While the TAO token saw a 22% price drop immediately following the halving, it has recently stabilised around 222 dollars as institutional interest in decentralised AI infrastructure grows.

Grayscale has filed with the US Securities and Exchange Commission (SEC) to launch a TAO-linked product, in what would be the first US-listed exchange-traded product designed to give investors exposure to Bittensor’s token.

The company submitted a registration statement on Tuesday for the Grayscale Bittensor Trust (TAO). Grayscale said the ETF would list on NYSE Arca under the ticker GTAO. The filing names Coinbase Custody Trust Company and BitGo Trust Company as custodians.

Grayscale confirmed the filing in a post on X, describing it as an early step toward converting the trust into an exchange-traded product. Chairman Barry Silbert also posted that the move reflects the pace of development in decentralised AI.

Read more: Mirae Asset Eyes Korbit in Potential $100M Crypto Exchange Deal

Grayscale Moves Forward With TAO 

Grayscale’s Bittensor trust launched privately in 2024 and began trading more broadly via public quotation earlier this month. 

The ETF filing comes shortly after Bittensor’s first halving in mid-December, which reduced the pace of new TAO issuance, similar in concept to Bitcoin’s scheduled supply cuts. TAO fell after the halving and has since stabilised around US$222 (AU$340), according to CoinGecko.

This filing basically puts Grayscale into an emerging, global race to list TAO-linked products. In Europe, Deutsche Digital Assets, a Germany-regulated exchange-traded products provider, has said it will list a Bittensor ETP on Switzerland’s SIX Swiss Exchange under the ticker STAO.

Bittensor is a decentralised network built around multiple application-specific subnets focused on AI workloads. Users earn TAO by providing computing resources that support those subnets.

Related: Uniswap Burns $596M in UNI After Near-Unanimous Governance Vote

The post Grayscale Targets Decentralised AI With First-Ever Bittensor (TAO) ETP Filing appeared first on Crypto News Australia.

Market Opportunity
Sleepless AI Logo
Sleepless AI Price(AI)
$0.03746
$0.03746$0.03746
+0.02%
USD
Sleepless AI (AI) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Trump Media & Crypto.com Partner For Shareholder Token Airdrop

Trump Media & Crypto.com Partner For Shareholder Token Airdrop

Trump Media & Technology Group (NASDAQ:DJT) has announced plans to distribute a new digital token to its shareholders, leveraging Crypto.com‘s infraread more
Share
Coinstats2026/01/01 00:23
Tria’s $20m beta surge: How a self-custodial neobank is redefining onchain finance

Tria’s $20m beta surge: How a self-custodial neobank is redefining onchain finance

CEO Vijit Katta shares with crypto.news how Tria is reshaping digital asset banking and paving the way for a frictionless, user-controlled financial future.
Share
Crypto.news2026/01/01 01:00
The FDA Is Trying To Make Corporate Free Speech Situational

The FDA Is Trying To Make Corporate Free Speech Situational

The post The FDA Is Trying To Make Corporate Free Speech Situational appeared on BitcoinEthereumNews.com. BENSENVILLE, ILLINOIS – SEPTEMBER 10: Flanked by U.S. Attorney General Pam Bondi (rear), and FDA Commissioner Marty Makary (R), Secretary of Health and Human Services Robert F. Kennedy Jr. speaks to the press outside Midwest Distribution after it was raided by federal agents on September 10, 2025 in Bensenville, Illinois. According to the company, various e-liquids were seized in the raid. (Photo by Scott Olson/Getty Images) Getty Images While running for President in 2008, Barack Obama famously chanted “Yes we can.” Love or hate his political views, Obama’s politics were quite effective. He was asking voters to think big, to envision a much better future. Advertisers no doubt approved. That’s because ads routinely evoke things not as they are, but as they could be. Gyms and exercise equipment companies don’t promote their locations and equipment with flabby, lumbering people, rather their ads show fit, upright, energetic individuals. A look ahead. Restaurants do the same with ads showing happy people enjoying impressively put together plates of food. Conversely, ads meant to convince smokers to quit have not infrequently shown the worst of the worst future downsides of the habit. The nature of advertising comes to mind as FDA commissioner Marty Makary puzzlingly brags that “The Trump Administration Is Taking On Big Pharma” in the New York Times. Makary laments pharmaceutical ads that “are filled with dancing patients, glowing smiles and catch jingles that drown out the fine print.” Not explained is whether Makary would be happier if drug companies placed ads with immobile patients, frowns, and funereal music. Seriously, what does he expect? Does he want drug companies to commit billions to drug development to accompany their achievements with imagery defined by misery? Has Makary stopped to contemplate the myriad shareholders lawsuits drugmakers would face if, upon risking staggering sums meant…
Share
BitcoinEthereumNews2025/09/18 06:29